MRK Kronos AI forecast
A 30-trading-day price forecast for Merck & Company Inc. (MRK) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Merck & Company Inc. at $133.28 on 2026-12-08, −6.0% from the last close of $141.82 on 2026-10-27. Eight out of ten sampled paths end between $130.25 and $140.72, and 1 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of MRK
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $148.06 | $142.87 | $150.09 |
| 2026-11-10 | $145.36 | $139.96 | $148.82 |
| 2026-11-17 | $137.54 | $127.77 | $141.48 |
| 2026-11-24 | $137.99 | $130.76 | $144.77 |
| 2026-12-01 | $136.82 | $129.65 | $145.42 |
| 2026-12-08 | $133.28 | $130.25 | $140.72 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for MRK?
- Kronos AI's median forecast for MRK is $133.28 in 30 trading days, −6.0% from the last close, with a 10–90% range of $130.25 to $140.72.
- Is the MRK Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC
- ABT — Abbott Laboratories